Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib was effective in treating both early and late onset alopecia areata.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

A new gene mutation causes insulin resistance in a girl and her mother.

Tofacitinib significantly regrows hair in severe alopecia without major side effects.

Tofacitinib can be effective in treating hair loss caused by alopecia areata.

Certain gene variations increase the risk of alopecia areata in Koreans.

A gene called HDAC9 might be a new factor in male-pattern baldness.

A specific DNA sequence caused hair loss in male mice by activating immune cells and increasing a certain immune signal.

Janus kinase inhibitors may effectively treat severe alopecia areata unresponsive to other treatments.

Researchers found a specific T cell receptor linked to severe drug reactions like Stevens-Johnson syndrome when patients take carbamazepine.

Tofacitinib helped an 8-year-old child recover from a type of hair loss that is hard to treat.

The conclusion is that a treatment called cp-asiAR can reduce hair loss and promote hair growth, making it a potential new therapy for androgenetic alopecia.

ARQ-234, a protein designed to treat atopic dermatitis, shows increased effectiveness in early testing.

ETS2 is crucial in squamous cell carcinoma development and could be a therapeutic target.

A new mutation in the ST14 gene causes a rare skin and hair disorder in a specific family.

Tofacitinib can regrow hair in alopecia areata patients, but some may experience flares during treatment.

The DNMT3B -579G>T polymorphism may increase the risk of colorectal cancer.

Tofacitinib helped some young children with severe hair loss grow their hair back without bad side effects.

Low-dose tofacitinib is effective and cheaper for severe alopecia areata.

The research identified and described a gene important for hormone conversion in endangered catfish, which varies in activity during different reproductive stages and after hormone treatment.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

Semecarpus anacardium leaf extracts may offer safe, effective cancer treatment alternatives.

A specific DNA pattern in Malassezia restricta may be linked to hair loss in men.

Tofacitinib is a safe and effective treatment for hair loss in children with Alopecia Areata.

Tofacitinib works well for treating alopecia areata, especially when combined with corticosteroids, but is less effective if the disease has lasted over 2 years.

MT-DADMe-ImmA can selectively kill head and neck cancer cells without harming normal cells.

Tofacitinib, a JAK inhibitor, improved hair regrowth in most patients with severe alopecia areata and had minimal side effects.

Acetyl tetrapeptide-3 was successfully made for use in hair loss treatments.

The study showed that a specific DNA sequence can control gene expression in hair growth areas of mice.